The landmark Randomized Aldactone Evaluation Study (RALES), published in 1999, showed that spironolactone, a potassium-sparing diuretic, improves outcomes in patients with severe heart failure.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback